These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3304785)

  • 41. [The MADI manual insulin dispensing device in the treatment of juvenile diabetes].
    Venhácová J; Zapletalová J
    Cesk Pediatr; 1989 Jul; 44(7):404-5. PubMed ID: 2676211
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment.
    Lahtela JT; Mustonen J; Pasternack A
    Clin Sci (Lond); 1995 Apr; 88(4):427-32. PubMed ID: 7789044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Alternative systems of insulin administration].
    Sinagra D; Randazzo C
    G Clin Med; 1989; 70(8-9):529-34. PubMed ID: 2680702
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of a portable drug administration system for long-term insulin administration to diabetics].
    Turakulov IaKh; Akbarov ZS; Allamiiarov BU; Akhmedova ND; Antonova TI
    Probl Endokrinol (Mosk); 1987; 33(2):16-9. PubMed ID: 3601886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subcutaneous versus intraperitoneal administration of insulin on post-prandial hyperglycaemia and glucose turnover in alloxan diabetic dogs.
    Rizza RA; Westland RE; Hall LD; Patton G; Haymond MW; Clemens AH; Gerich JE; Service FJ
    Diabetologia; 1982 Jul; 23(1):61-4. PubMed ID: 6749587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The absorption of subcutaneously injected insulin.
    de Meijer PH; Lutterman JA; van 't Laar A
    Neth J Med; 1989 Apr; 34(3-4):210-27. PubMed ID: 2657457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of plasma insulin profiles after subcutaneous administration of insulin by jet spray and conventional needle injection in patients with insulin-dependent diabetes mellitus.
    Pehling GB; Gerich JE
    Mayo Clin Proc; 1984 Nov; 59(11):751-4. PubMed ID: 6387316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphoblastic lymphoma arising at the insulin injection sites in a child with type 1 diabetes mellitus.
    Wang JD; Chang TK; Shu SG
    J Pediatr; 2010 Dec; 157(6):1043-1043.e1. PubMed ID: 20547397
    [No Abstract]   [Full Text] [Related]  

  • 49. [Extreme subcutaneous and intramuscular insulin resistance at type 1 diabetes mellitus].
    Pinheiro A; Tácito LH; Pires AC
    Arq Bras Endocrinol Metabol; 2011 Apr; 55(3):233-7. PubMed ID: 21655874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraperitoneal insulin affects insulin-like growth factor binding protein-1 in a well-controlled type I diabetic patient.
    Hopkins KD; Russell-Jones DL; Lehmann ED; Wheeler MJ; Sönksen PH
    Diabetes Care; 1993 Oct; 16(10):1404-5. PubMed ID: 7505735
    [No Abstract]   [Full Text] [Related]  

  • 51. Possible effectiveness of plasmapheresis and immunosuppressive therapy in reversing subcutaneous insulin resistance: a case report.
    Vannini P; Forlani G; Giangiulio S; Santacroce G; Ciavarella A; Mustacchio A
    Diabete Metab; 1989; 15(2):98-101. PubMed ID: 2500372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of two commonly used insulin injection techniques.
    Heine RJ; Sikkenk AC; Bilo HJ; van der Meer J; van der Veen EA
    Diabet Med; 1985 May; 2(3):175-6. PubMed ID: 2952413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Free-insulin profiles after intraperitoneal, intramuscular, and subcutaneous insulin administration.
    Micossi P; Cristallo M; Librenti MC; Petrella G; Galimberti G; Melandri M; Monti L; Spotti D; Scavini M; Di Carlo V
    Diabetes Care; 1986; 9(6):575-8. PubMed ID: 3542451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraperitoneal insulin absorption after long-term intraperitoneal insulin therapy.
    Scavini M; Pincelli A; Petrella G; Galimberti G; Zager PG; Torri M; Pozza G
    Diabetes Care; 1995 Jan; 18(1):56-9. PubMed ID: 7698048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Collaborative studies of the effects of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. Conclusions. The Kroc Collaborative Study Group.
    Diabetes; 1985 Aug; 34 Suppl 3():87-9. PubMed ID: 3894131
    [No Abstract]   [Full Text] [Related]  

  • 56. Insulin goes metric: a time for reveiw.
    Laugharne E
    Can Nurse; 1975 Feb; 71(2):22-4. PubMed ID: 1116113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Insulin pens filled in advance are better than rechargeable ones according to patients with diabetes].
    Wollesen F; Mikkelsen E
    Lakartidningen; 1991 May; 88(22):2052-3. PubMed ID: 2051872
    [No Abstract]   [Full Text] [Related]  

  • 58. Influence of concentration on the kinetics of SC-infused insulin. Comparison between square-wave SC infusion and bolus SC injection.
    Murat A; Slama G
    Metabolism; 1985 Feb; 34(2):120-3. PubMed ID: 3881645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model.
    Teigen IA; Åm MK; Carlsen SM; Christiansen SC
    Basic Clin Pharmacol Toxicol; 2022 Jun; 130(6):623-631. PubMed ID: 35416407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin-injection-site reactions associated with type I latex allergy.
    Roest MA; Shaw S; Orton DI
    N Engl J Med; 2003 Jan; 348(3):265-6. PubMed ID: 12529475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.